Enducal, Nida P.
HRN: 15-51-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2024
CEFTRIAXONE 1G (VIAL)
02/01/2024
02/07/2024
IVTT
2g
OD
Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes